News

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...
You don’t have to start out with tons of cash to grow wealth. Biotech stocks offer you a great opportunity to get in on ...
More than a dozen Houston medical professionals and health care business owners were charged as part of a nationwide ...